威尔药业
(603351)
| 流通市值：31.84亿 | | | 总市值：32.18亿 |
| 流通股本：1.34亿 | | | 总股本：1.35亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 329,832,361.62 | 1,155,839,777.59 | 828,679,872.71 | 522,970,497.42 |
| 营业收入 | 329,832,361.62 | 1,155,839,777.59 | 828,679,872.71 | 522,970,497.42 |
| 二、营业总成本 | 290,059,404.32 | 1,037,710,321.21 | 744,005,886.09 | 465,641,890.73 |
| 营业成本 | 243,995,162.64 | 839,036,256.46 | 602,966,773.68 | 375,002,583.22 |
| 税金及附加 | 2,229,232.8 | 7,321,324.98 | 5,357,928.06 | 3,004,398.26 |
| 销售费用 | 2,882,667.77 | 12,835,240.56 | 8,681,853.98 | 5,496,841.78 |
| 管理费用 | 22,793,522.43 | 108,665,944.46 | 76,213,300.26 | 50,147,701.36 |
| 研发费用 | 15,768,635.95 | 55,644,643.28 | 40,564,145.19 | 25,405,046.22 |
| 财务费用 | 2,390,182.73 | 14,206,911.47 | 10,221,884.92 | 6,585,319.89 |
| 其中:利息费用 | 3,184,113.95 | 14,174,206.99 | 10,870,498.06 | 7,303,106.83 |
| 其中:利息收入 | 207,013.92 | 783,310.41 | 534,959.2 | 339,737.04 |
| 加:公允价值变动收益 | -47,700 | 1,439,968.42 | 95,450.53 | 97,250.53 |
| 加:投资收益 | - | 100.03 | 100.03 | - |
| 资产减值损失(新) | - | -3,934,256.3 | -1,512,551.67 | -1,512,551.67 |
| 信用减值损失(新) | -218,985.33 | -51,927.94 | -305,292.88 | -164,631.66 |
| 其他收益 | 1,334,761.46 | 6,193,186.73 | 996,352.45 | 851,000.15 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 40,841,033.43 | 121,776,527.32 | 83,948,045.08 | 56,599,674.04 |
| 加:营业外收入 | - | 18,868.97 | 18,869.61 | 18,868.97 |
| 减:营业外支出 | 11,681.45 | 354,160.78 | 170,200.66 | 149,822.84 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 40,829,351.98 | 121,441,235.51 | 83,796,714.03 | 56,468,720.17 |
| 减:所得税费用 | 7,312,919.77 | 12,326,673.3 | 7,816,864.01 | 4,498,055.02 |
| 六、净利润 | 33,516,432.21 | 109,114,562.21 | 75,979,850.02 | 51,970,665.15 |
| 持续经营净利润 | 33,516,432.21 | 109,114,562.21 | 75,979,850.02 | 51,970,665.15 |
| 归属于母公司股东的净利润 | 34,603,545.42 | 112,199,192.87 | 78,271,460.39 | 53,386,352.5 |
| 少数股东损益 | -1,087,113.21 | -3,084,630.66 | -2,291,610.37 | -1,415,687.35 |
| (一)基本每股收益 | 0.26 | 0.83 | 0.58 | 0.39 |
| (二)稀释每股收益 | 0.26 | 0.83 | 0.58 | 0.39 |
| 九、综合收益总额 | 33,516,432.21 | 109,114,562.21 | 75,979,850.02 | 51,970,665.15 |
| 归属于母公司股东的综合收益总额 | 34,603,545.42 | 112,199,192.87 | 78,271,460.39 | 53,386,352.49 |
| 归属于少数股东的综合收益总额 | -1,087,113.21 | -3,084,630.66 | -2,291,610.37 | -1,415,687.34 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-31 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |